Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Prema Cognition, a leader in digital precision memory assessments, today announced a ...
Experts think that the biological beginnings of Alzheimer's disease might start showing up a long time before symptoms such ...
Objective To evaluate systematic reviews of randomised controlled trials (RCTs) on the effects of exercise on general cognition, memory and executive function across all populations and ages. Methods ...
On Thursday, Nexalin Technology, Inc (NASDAQ:NXL) (NASDAQ:NXLIW) announced results from a clinical trial of its Deep Intracranial Frequency Stimulation (DIFS) technology for mild Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results